ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

In Brief: Pagano to Retire As Lineberger Director; Nursing Society Elects Yarbro As President

September 20, 1996

Additional DCE Contract Concepts

November 16, 1984

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Senate Confirms McClellan For FDA

October 25, 2002